Uncover Insights on Hamilton Lane for Investors

Shares of Finance sector company Hamilton Lane moved -3.7% today, and are now trading at a price of $192.02. The Large-Cap stock's daily volume was 406,061 compared to its average volume of 442,492. The S&P 500 index returned a -0.0% performance.

Hamilton Lane Incorporated is a private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. The company is based in Philadelphia and has 700 full time employees. Its market capitalization is $10,644,474,880. Hamilton Lane currently offers its equity investors a dividend that yields 0.9% per year.

6 analysts are following Hamilton Lane and have set target prices ranging from $175.0 to $215.0 per share. On average, they have given the company a rating of hold. At today's prices, HLNE is trading 0.36% away from its average analyst target price of $191.33 per share.

Over the last year, HLNE's share price has increased by 96.2%, which represents a difference of 64.9% when compared to the S&P 500. The stock's 52 week high is $203.72 per share whereas its 52 week low is $96.38. Hamilton Lane's average free cash flow over the last 5 years has been $147.13 Million, but they have been decreasing at an average rate of -0.1%. This may prove a challenge to the long term sustainability of the stock's upwards trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 120,852 11,073 109,779 -50.51
2022 226,589 4,747 221,842 37.79
2021 169,523 8,526 160,997 -5.03
2020 188,158 18,637 169,521 48.19
2019 116,373 1,978 114,395 7.66
2018 111,622 5,366 106,256
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS